Advertisement
Screener

Lite Strategy, Inc. (LITS) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.2 / 5 stars · 45/104 Roast Me

Lite Strategy, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Lite Strategy, Inc. (LITS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.02 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-13

  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.02M shares, a 416.03% increase year-over-year.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 4.64M shares, a 338.56% increase year-over-year.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 3.91M shares, a 218.58% increase year-over-year.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 973.00K shares, a 34.08% decline year-over-year.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 972.00K shares, a 33.42% decline from fiscal 2024.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.46M shares, a 5.19% increase from fiscal 2023.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.39M shares, a 3.41% decline from fiscal 2022.
  • Lite Strategy, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.44M shares, a 92.93% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-03-315.02M shares
10-Q · filed 2026-05-13
5.02M shares
10-Q · filed 2026-05-13
2025-12-314.64M shares
10-Q · filed 2026-02-17
4.64M shares
10-Q · filed 2026-02-17
2025-09-303.91M shares
10-Q · filed 2025-11-14
2025-06-30972.00K shares
10-K · filed 2025-09-26
2025-03-31973.00K shares
10-Q · filed 2026-05-13
973.00K shares
10-Q · filed 2026-05-13
2024-12-311.06M shares
10-Q · filed 2026-02-17
1.06M shares
10-Q · filed 2026-02-17
2024-09-301.23M shares
10-Q · filed 2025-11-14
2024-06-301.46M shares
10-K · filed 2025-09-26
2024-03-311.48M shares
10-Q · filed 2025-05-13
1.48M shares
10-Q · filed 2025-05-13
2023-12-311.50M shares
10-Q · filed 2025-02-12
1.50M shares
10-Q · filed 2025-02-12
2023-09-301.55M shares
10-Q · filed 2024-11-12
2023-06-301.39M shares
10-K · filed 2024-09-19
2023-03-312.16M shares
10-Q · filed 2024-05-09
2.18M shares
10-Q · filed 2024-05-09
2022-12-312.17M shares
10-Q · filed 2024-02-13
43.51M shares
10-Q · filed 2023-02-09
2.18M shares
10-Q · filed 2024-02-13
43.67M shares
10-Q · filed 2023-02-09
2022-09-302.19M shares
10-Q · filed 2023-11-09
43.83M shares
10-Q · filed 2022-11-14
2022-06-301.44M shares
10-K · filed 2023-09-26
28.75M shares
10-K · filed 2022-09-08
2022-03-311.83M shares
10-Q · filed 2023-05-11
36.68M shares
10-Q · filed 2022-05-23
1.31M shares
10-Q · filed 2023-05-11
26.17M shares
10-Q · filed 2022-05-23
2021-12-3120.69M shares
10-Q · filed 2023-02-09
20.91M shares
10-Q · filed 2023-02-09
2021-09-3021.14M shares
10-Q · filed 2022-11-14
2021-06-3020.33M shares
10-K · filed 2022-09-08
2021-03-3132.65M shares
10-Q · filed 2022-05-23
21.40M shares
10-Q · filed 2022-05-23
2020-12-3115.56M shares
10-Q/A · filed 2022-05-23
15.78M shares
10-Q/A · filed 2022-05-23
2020-09-3015.56M shares
10-Q/A · filed 2022-05-23
2020-06-3027.09M shares
10-K · filed 2022-09-08
2020-03-3127.13M shares
10-Q · filed 2021-05-06
27.13K shares
10-Q · filed 2020-05-07
27.04M shares
10-Q · filed 2021-05-06
27.04K shares
10-Q · filed 2020-05-07
2019-12-3126.99M shares
10-Q · filed 2021-02-04
26.99K shares
10-Q · filed 2020-02-06
26.99M shares
10-Q · filed 2021-02-04
26.99K shares
10-Q · filed 2020-02-06
2019-09-3026.99M shares
10-Q · filed 2020-11-10
26.99K shares
10-Q · filed 2019-11-07
2019-06-3016.15M shares
10-K/A · filed 2022-05-23
16.15K shares
10-K · filed 2019-08-28
2019-03-3124.21K shares
10-Q · filed 2020-05-07
24.21M shares
10-Q · filed 2019-05-09
18.82K shares
10-Q · filed 2020-05-07
18.82M shares
10-Q · filed 2019-05-09
2018-12-318.16K shares
10-Q · filed 2020-02-06
8.16M shares
10-Q · filed 2019-02-07
16.13K shares
10-Q · filed 2020-02-06
16.13M shares
10-Q · filed 2019-02-07
2018-09-3024.09K shares
10-Q · filed 2019-11-07
24.09M shares
10-Q · filed 2018-11-08
2018-06-309.47M shares
10-K · filed 2020-09-09
9.47K shares
10-K · filed 2018-08-30
2018-03-315.91M shares
10-Q · filed 2019-05-09
7.91M shares
10-Q · filed 2019-05-09
2017-12-318.64M shares
10-Q · filed 2019-02-07
8.91M shares
10-Q · filed 2019-02-07
2017-09-309.18M shares
10-Q · filed 2018-11-08
2017-06-307.33K shares
10-K · filed 2019-08-28
7.38M shares
10-K · filed 2017-09-05
2017-03-318.07M shares
10-Q · filed 2018-05-09
8.07M shares
10-Q · filed 2017-05-04
7.58M shares
10-Q · filed 2018-05-09
7.58M shares
10-Q · filed 2017-05-04
2016-12-317.92M shares
10-Q · filed 2018-02-08
7.92M shares
10-Q · filed 2017-02-08
7.71M shares
10-Q · filed 2018-02-08
7.71M shares
10-Q · filed 2017-02-08
2016-09-308.12M shares
10-Q · filed 2017-11-08
8.39M shares
10-Q · filed 2016-11-09
2016-06-306.63K shares
10-K · filed 2018-08-30
7.08M shares
10-K · filed 2016-09-06
2016-03-316.69M shares
10-Q · filed 2017-05-04
6.55M shares
10-Q · filed 2017-05-04
6.77M shares
10-Q · filed 2016-05-05
2015-12-316.58M shares
10-Q · filed 2017-02-08
6.48M shares
10-Q · filed 2017-02-08
6.60M shares
10-Q · filed 2016-02-05
2015-09-306.54M shares
10-Q · filed 2016-11-09
2015-06-306.53M shares
10-K · filed 2017-09-05
5.64M shares
10-K · filed 2015-09-02
2015-03-315.91M shares
10-Q · filed 2016-05-05
2014-12-316.71M shares
10-Q · filed 2016-02-05
2014-09-306.85M shares
10-Q · filed 2015-11-06
2014-06-306.50M shares
10-K · filed 2016-09-06
2014-03-316.32M shares
10-Q · filed 2015-05-07
2013-12-316.42M shares
10-Q · filed 2015-02-06
2013-09-306.42M shares
10-Q · filed 2014-11-06
2013-06-306.10M shares
10-K · filed 2015-09-02
2013-03-316.03M shares
10-Q · filed 2014-05-08
2012-12-315.46M shares
10-Q · filed 2014-02-11
2012-09-301.94M shares
10-Q · filed 2013-11-08
11.63M shares
10-Q · filed 2012-11-13
2012-06-301.89M shares
10-K · filed 2014-09-09
8.84M shares
10-K · filed 2012-09-18
2012-03-311.40M shares
10-Q · filed 2013-05-09
2011-12-311.40M shares
10-Q · filed 2013-02-12
2011-09-308.27M shares
10-Q · filed 2012-11-13
2011-06-301.68M shares
10-K · filed 2012-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38